Molecular characterization of upper urinary tract urothelial carcinoma and paired bladder cancer recurrences
J. Alberto Nakauma-González(Erasmus MC Cancer Institute), Joost L. Boormans(Erasmus MC), M. Eckstein, Ivan Bièche(Centre National de la Recherche Scientifique), E. Matas-Rico, Martina Álvarez(Hospital Costa del Sol), Arndt Hartmann(Universitätsklinikum Erlangen), J. Helleman, Y. Allory, Juan Daniel Prieto Cuadra(Hospital Clínico Universitario Virgen de la Victoria), Justine Pasanisi(Centre National de la Recherche Scientifique), T. Van Doeveren, V. Bahlinger, Thomas Wilhelm, B. Herrera-Imbroda, Danijel Sikic(Friedrich-Alexander-Universität Erlangen-Nürnberg), María José Lozano, Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), I. García Munoz, Harmen J.G. van de Werken(Erasmus MC), M. Fernanda Lara(Andalusian Centre for Nanomedicine and Biotechnology), Lázaro García-Morales(Instituto Politécnico Nacional)
Cited by 0
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411